eBPDR System Instructions

For use by manufacturers to report biological product deviations (BPD) to the Center for Biologics Evaluation and Research (CBER) that may affect the safety, purity, or potency of a distributed product in accordance with 21 CFR, Part 600.14 or 606.171. Also, for use...

Products Approved for Anthrax

Image Anthim (obiltoxaximab) injection, for intravenous useAnthrasil [Anthrax Immune Globulin Intravenous (Human)], sterile solution for infusion (CBER)Biothrax (Anthrax Vaccine Adsorbed) (CBER)Ciprofloxacin Cyfendus (FDA approved 7/20/2023)Doxycycline and Other...

Novel Drug Approvals at FDA

What are “Novel” Drugs?”Novel” drugs are new drugs never before approved or marketed in the U.S. See Drugs@FDA for information about all of CDER’s approved drugs and biological products. Helping Guide the Way for New MedicinesInnovative drugs...